Related Experiment Video
Updated: Sep 23, 2025
09:02
Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
21.5K
Can Gilbert's syndrome mitigate chronic lymphocytic leukemia?
Leonid L Yavorkovsky1, Lev Shvidel2
1Kaiser Permanente San Jose Medical Center, Oncology Division, 270 International Circle, San Jose, CA, 95119 United States of America.
Leukemia Research Reports
|May 16, 2022
Summary
Individuals with Gilbert's syndrome (GS) and chronic lymphocytic leukemia (CLL) showed less need for therapy and reduced mortality. Elevated bilirubin in GS may protect against CLL progression by reducing oxidative stress.
Area of Science:
- Hematology
- Oncology
- Biochemistry
Background:
- Chronic lymphocytic leukemia (CLL) is characterized by oxidative stress.
- Gilbert's syndrome (GS) is associated with elevated bilirubin and antioxidant effects.
Purpose of the Study:
- To investigate the potential protective effect of Gilbert's syndrome on chronic lymphocytic leukemia progression.
- To explore the role of oxidative stress in CLL pathogenesis and potential therapeutic targeting.
Main Methods:
- Pilot study comparing outcomes in patients with both CLL and GS (GS/CLL cohort) versus the general CLL population.
- Analysis of therapy requirements and CLL-related mortality.
Main Results:
- The GS/CLL cohort required less therapy compared to the general CLL population.
- Reduced CLL-related mortality was observed in the GS/CLL cohort.
- Findings suggest a potential safeguarding effect of elevated bilirubin in GS against CLL pathogenesis.
Conclusions:
- Elevated bilirubin in Gilbert's syndrome may attenuate oxidative stress, potentially offering a protective effect in chronic lymphocytic leukemia.
- Oxidative stress emerges as a potential pathogenetic and therapeutic target for mitigating CLL.
